Printer Friendly

SCHERER/MARQUEST BOND OFFER ENDS

 ENGLEWOOD, Colo., June 14 /PRNewswire/ -- Marquest Medical Products Inc. (NASDAQ: MMPI) today announced that approximately 90 percent of the defaulted Swiss bonds of Marquest, for which a combination of Marquest securities and Scherer Healthcare Inc. (NASDAQ: SCHR) Convertible Preferred Stock was offered, were tendered as of the expiration, as extended, of the Exchange Offer.
 The offer was contingent upon 95 percent of the bonds being tendered. Charles M. Obermeyer, president and director of Marquest, stated that, "Both companies expect to proceed with acceptance of the tendered bonds."
 Marquest Medical Products is an international manufacturer and distributor of specialty cardiopulmonary support, respiratory and anesthesia disposable devices.
 Scherer Healthcare provides healthcare and pharmaceutical services, including infectious medical waste disposal, medical and surgical supplies, pharmaceutical research based on computer-assisted design, and over-the-counter pharmaceuticals.
 -0- 6/14/93
 /CONTACT: Charles M. Obermeyer of Marquest Medical Products, 303-790-4835/
 (MMPI SCHR)


CO: Marquest Medical Products Inc.; Scherer Healthcare Inc. ST: Colorado IN: MTC SU: OFR

BB -- DV002 -- 1378 06/14/93 07:30 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 14, 1993
Words:168
Previous Article:CIRCUIT CITY STORES, INC., REPORTS FIRST QUARTER RESULTS
Next Article:DAMARK NAMES STEPHEN PLATT AS SENIOR VICE PRESIDENT OF MARKETING AND NEW BUSINESS DEVELOPMENT
Topics:


Related Articles
SCHERER HEALTHCARE ANNOUNCES REVISED AGREEMENT TO ACQUIRE UP TO 65 PERCENT OF MARQUEST MEDICAL PRODUCTS
MARQUEST MEDICAL PRODUCTS ANNOUNCES REVISED AGREEMENT
CHARLES OBERMEYER ELECTED PRESIDENT OF MARQUEST MEDICAL PRODUCTS INC.
SCHERER HEALTHCARE/MARQUEST MEDICAL FINANCING COMPLETED
SCHERER HEALTHCARE/MARQUEST MEDICAL FINANCING COMPLETED
MARQUEST MEDICAL PRODUCTS ANNOUNCES FDA COMPLETES ROUTINE INSPECTION
MARQUEST MEDICAL PRODUCTS FINANCIAL RESTRUCTURING PROGRESS
MARQUEST MEDICAL PRODUCTS FINANCIAL RESTRUCTURING PROGRESS
ALAMAR BIOSCIENCES RAISES MORE FUNDS THAN EXPECTED THROUGH PRIVATE FINANCING;
R.P. Scherer 'BBB' Rated $100 Million Senior Debt and $75 Million Shelf are Affirmed By Fitch -- Fitch Financial Wire --

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters